Q-PID
Quality of life and Paracetamol In advanced Dementia (Q-PID) study
To Dutch page
Short description
A Dutch study assessing the effect of paracetamol on quality of life, functioning, care dependency, neuropsychiatric symptoms and pain in persons with advanced dementia living in long-term care facilities.
Researchers
Prof. dr. W.P. Achterberg, professor of Old Age MedicineProf. dr. B.S. Husebo, professor of elderly care medicine (No)
Dr. M.A.A. Caljouw, assistant professor
Drs. P.H. van Dam, elderly care physician, PhD candidate
Participating organisations
WZH, Laurens, Argos zorggroep, Marente, Pieter van Foreest, Topaz, Saffier, Aafje and Florence
Contact
Drs. Paulien van Dam, elderly care physician, PhD candidate
Start study
2016
Expected completion
2022
Description
No proven effective interventions on quality of life (QoL) are available for persons with dementia in a long-term care facility (LTCF). However, several interventions are effective in diminishing mediators of QoL (i.e. challenging behaviour, depressed mood, sleeping disorders), including pain treatment. Un(der)diagnosed and un(der)treated pain is a serious en frequent problem in persons with dementia. Also, although pain is difficult to assess in this group, the impact on QoL is probably considerable. There is evidence that pain has a negative impact on behaviour, mood, functioning and social participation, and benefit may be derived from use of paracetamol.
Aims of the Q-PID study: to evaluate the effect of scheduled pain treatment with paracetamol on QoL, neuropsychiatric symptoms, ADL function, pain, care dependency, and (change in) use of psychotropic and pain medication in persons with advanced dementia living in long-term care facilities.
In collaboration with
SEFAS (Centre for Elderly Care and Nursing Home Medicine, Bergen Norway)
Financing
ZonMw (HGOG)
Ministry of Public Health, Wellbeing and Sports
Publications
van Dam, P.H., Achterberg, W.P., Husebo, B.S., Caljouw, M.A.A. Does paracetamol improve quality of life, discomfort, pain and neuropsychiatric symptoms in persons with advanced dementia living in long-term care facilities? A randomised double-blind placebo-controlled crossover (Q-PID) trial. BMC Med 18, 407 (2020). https://doi.org/10.1186/s12916-020-01858-6
van Dam, P.H., Caljouw, M.A.A., Slettebø, D.D., Achterberg, W.P., Husebo, B.S. Quality of Life and Pain Medication Use in Persons With Advanced Dementia Living in Long-Term Care Facilities. J Am Med Dir Assoc. 2019 Apr 11
van Dam, P.H., Achterberg, W.P., Gussekloo, J., Husebo, B.S., Caljouw, M.A.A. Quality of life and paracetamol in advanced dementia (Q-PID): protocol of a randomised double-blind placebo-controlled crossover trial
Posterpresentatie projectleidersbijeenkomst HGOG, Utrecht, 11 oktober 2016: Dam PH van, Caljouw MAA, Achterberg WP. Het effect van paracetamol op kwaliteit van leven van mensen met matige tot (zeer) ernstige dementie. Q-PID studie.